The FreeStyle Libre from Abbott Diabetes is identified as a Flash Glucose Monitoring system as a end result of it provides a “flash” of a glucose reading whenever you scan the sensor with the hand held receiver or smartphone app. The company submitted the Tempo Smart Button to the FDA in 2021, as did Welldoc with its new app. The expectation is the system will get approval and launch in 2022. Lilly is collaborating with Welldoc to integrate a model new version of Welldoc’s BlueStar app into what’s known as Lilly’s Tempo Personalized Diabetes Management Platform. The first model of…
